Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Guorui Pharmaceutical is a pharmaceutical manufacturing company and a core subsidiary of Sichuan Biokin Pharmaceutical (also known as Baili-Bio). Based in Leshan, Sichuan, the company operates a large-scale production base specializing in the manufacture of chemical drugs, including sterile injectables and oral formulations. Its product portfolio primarily covers therapeutic areas such as anesthesia, anti-infectives, parenteral nutrition, and pediatrics. As the manufacturing arm of the Biokin group, it supports the commercialization of the group's extensive generic drug portfolio and provides critical production capacity for its innovative pipeline of antibody-drug conjugates and multispecific antibodies. The company's facilities are GMP-certified and serve both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Guorui Pharmaceutical.